Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation

Pessina Federico; Navarria Pierina; Cozzi Luca; Tomatis Stefano; Ascolese Anna M.; Franzese Ciro; Toschi Luca; Santoro Armando; De Rose Fiorenza; Franceschini Davide; Bello Lorenzo; Scorsetti Marta

首页> 外文期刊>British Journal of Radiology >Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation

【24h】

Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation

机译：用不同局部治疗策略治疗的非小细胞肺癌（NSCLC）有限脑转移患者（BMS）的患者的结果评估：单一研究所评价

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To evaluate the outcome of patients with non-small- cell lung cancer (NSCLC) with limited brain metastases (BMs) treated with local approaches omitting whole-brain radiation therapy (WBRT).

机译：目的：评价用局部方法处理有限脑转移（BMS）的非小细胞肺癌（NSCLC）患者的结果，省略全脑放射治疗（WBRT）。

著录项

来源
《British Journal of Radiology》 |2017年第1072期|共9页
作者
Pessina Federico; Navarria Pierina; Cozzi Luca; Tomatis Stefano; Ascolese Anna M.; Franzese Ciro; Toschi Luca; Santoro Armando; De Rose Fiorenza; Franceschini Davide; Bello Lorenzo; Scorsetti Marta;
展开▼
作者单位

Humanitas Canc Ctr &

Res Hosp Neurooncol Surg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Radiotherapy &

Radiosurg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Radiotherapy &

Radiosurg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Radiotherapy &

Radiosurg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Radiotherapy &

Radiosurg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Radiotherapy &

Radiosurg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Haematol &

Oncol Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Haematol &

Oncol Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Radiotherapy &

Radiosurg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Radiotherapy &

Radiosurg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Neurooncol Surg Rozzano Italy;

Humanitas Canc Ctr &

Res Hosp Radiotherapy &

Radiosurg Rozzano Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Whole brain radiotherapy concomitant or sequential Vm26/DDP in treating small cell lung cancer patients with brain metastases [J] . Mingyue Liu, Yun Zhou, Qian Han, 中德临床肿瘤学杂志：英文版 . 2010,第001期
2. Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases [J] . Ling-Ling Kong, Lin-Lin Wang, Li-Gang Xing, 慢性疾病与转化医学（英文） . 2017,第004期
3. Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases [J] . Ling-Ling Kong, Lin-Lin Wang, Li-Gang Xing, 慢性疾病与转化医学：英文版 . 2017,第004期
4. Therapy for non-small-cell lung cancer patients with brain metastasis Therapy for non-small-cell lung cancer patients with brain metastasis [J] . Bing Li, Yuchen Bao Co-first author, Bin Chen, 中德临床肿瘤学杂志（英文版） . 2014,第010期
5. WHAT IS THE OPTIMAL THERAPEUTIC STRATEGY FOR LIMITED BRAIN METASTASES (BMS) FROM NON SMALL CELL LUNG CANCER (NSCLC)? PROGNOSTIC FACTORS CONDITIONING BRAIN CONTROL AND PATIENTS OUTCOME [J] . Navarria P., Pessina F., Toschi L., Neuro-Oncology . 2017,第MAySuppla3期

机译：非小细胞肺癌（NSCLC）局限性脑转移（BMS）的最佳治疗策略是什么？影响脑控制和患者结果的预后因素
6. 9055 Outcome of non-small-cell lung cancer (NSCLC) patients treated for brain metastases (BM) in a single institution [J] . M.Chaubet, N.Abedallaa, C. LePechoux, European Journal of Cancer Supplements . 2009,第2期

机译：在一家机构中9055接受脑转移（BM）治疗的非小细胞肺癌（NSCLC）患者的结果
7. 9055 Outcome of non-small-cell lung cancer (NSCLC) patients treated for brain metastases (BM) in a single institution [J] . M.Chaubet, N.Abedallaa, C. LePechoux, European Journal of Cancer Supplements . 2009,第2期

机译：在一家机构中9055接受脑转移（BM）治疗的非小细胞肺癌（NSCLC）患者的结果
8. Identification of Rules for Brain Metastases and Survival Time Prediction for Small Cell Lung Cancer Patients [C] . Kwei Aryeetey, Wojciech Ziarko, Patricia Tai, International Symposium on "Intelligent Information Systems X", Jun 18-22, 2001, Zakopane, Poland . 2001

机译：小细胞肺癌患者脑转移和生存时间预测规则的确定
9. Pre-Treatment Radiomics Models for Clinical Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC) [D] . Shaffer, Nathan Allen. 2021

机译：早期非小细胞肺癌临床结果的预处理辐射瘤模型（NSCLC）
10. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation [O] . Federico Pessina, Pierina Navarria, Luca Cozzi, 2017

机译：用不同的局部治疗策略治疗非小细胞肺癌（NSCLC）局限性脑转移（BMs）患者的结果评估：单个机构评估
11. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation [O] . Federico Pessina, Pierina Navarria, Luca Cozzi, 2017

机译：用不同局部治疗策略治疗的非小细胞肺癌（NSCLC）有限脑转移患者（BMS）的患者的结果评估：单一研究所评价
12. Evaluation of Biomarkers Predictive of Benefit from the PD-1 Inhibitor MK-3475 in Patients with Non-Small Cell Lung Cancer and Brain Metastases. [R] . Goldberg, S. B. 2017

机译：评估生物标志物预测pD-1抑制剂mK-3475对非小细胞肺癌和脑转移患者的益处。

Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation

摘要

著录项

相似文献

相关主题

期刊订阅